Loading clinical trials...
Loading clinical trials...
Phase II Study of Peri-Operative Modified Folfirinox in Localized Pancreatic Cancer
Conditions
Interventions
oxaliplatin
leucovorin calcium
+4 more
Locations
9
United States
Smilow Cancer Hospital at Fairfield
Fairfield, Connecticut, United States
Smilow Cancer Hospital at Guilford
Guilford, Connecticut, United States
Smilow Cancer Hospital at St. Francis Hospital
Hartford, Connecticut, United States
Yale University
New Haven, Connecticut, United States
Smilow Cancer Hospital at North Haven
North Haven, Connecticut, United States
Smilow Cancer Hospital at Orange
Orange, Connecticut, United States
Start Date
March 25, 2014
Primary Completion Date
August 16, 2022
Completion Date
January 14, 2024
Last Updated
March 6, 2026
NCT06423326
NCT05334069
NCT01013649
NCT04449679
NCT01835041
NCT04400903
Lead Sponsor
Yale University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions